Neurodevelopment in Health and Disease

Image: Hill-Yardin Group

Neurodevelopment in Health and Disease

Neurodevelopment in Health and Disease

We are a multidisciplinary research program identifying the determinants of healthy brain development, and combating the early origins of neurological disease across the lifespan.

Contact us

To contact an individual researcher please see our who we are page. Alternatively, reach out to our Program Leader, Professor David Walker using the button below.

Email David Walker

Research focus

We are Australian leaders in functional and structural examination of the brain and peripheral nervous system. We are discovering the fundamental neural changes that occur during development, and how these might be changed or disrupted by disease and environmental impacts. Our research across the lifespan is advancing our understanding of how to keep the brain healthy for longer.

Capabilities

Our research addresses fundamental neurobiological questions and important biomedical problems including: poor fetal growth, cerebral palsy, obesity, stress, cognitive dysfunction, cardiovascular disease, stroke, sleep disorders, and the origins of behavioural abnormalities such as autism.

We use molecular, pharmacological, microfluidics, neurophysiological, and behavioural assessment techniques to enable the investigation of oxidative stress, neurogenesis and myelination, mitochondrial function, regulation of brain energy supply, neuroendocrinology of stress, quantitative assessment of behaviour and cognition, and detailed evaluation of brain structure using MRI/MRS, electrophysiology, qPCR, Next-Gen sequencing, super-resolution microscopy and immunohistochemistry.

Our impact

We work with a range of Australian and global organisations to provide innovative discoveries into maximizing brain health.

Who we are

Find out more

Latest NDHD news

Find out more

Latest Health and Biomedical Science news

Top five health tech trends give a glimpse of the future of healthcare

10 Sep 2024

A new report reveals the five most significant tech transformations for health – and how to advance adoption over the next 12 months.

Low-carb, high-fat diets boost diabetes risk

06 Sep 2024

A comprehensive study of 40,000 Australians over 17 years found low-carbohydrate, high-fat diets increased a person's chances of developing diabetes by 20%.

A parent sits with their child while they have a telehealth appointment on the laptop. A doctor is on the screen talking to them.

Digital solutions for active healthy living

16 Jul 2024

RMIT Europe has contributed to a European project aimed at empowering citizens to live a healthy and active lifestyle.

A person is holding an aspirin tablet and a glass of water. Credit: Photographee.eu, Adobe Stock

Low-dose aspirin could help prevent pregnancy complications caused by flu infections

03 Jul 2024

A world-first study has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy.

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

More information

Acknowledgement of Country

More information